Lentiviral Vector-Based Therapeutic Vaccine (Theravectys)

N/A

Report date: 2024/04/10 12:03:42

Base Information

Drug NameLentiviral Vector-Based Therapeutic Vaccine (Theravectys)

Drug Alias NameLenti-HPV-07

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsUterine Cervical NeoplasmsOropharyngeal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesTheravectys Sa

China Registration ClassN/A

Develop Information

Active CompaniesTheravectys Sa

Inactive CompaniesN/A

Active IndicationsUterine Cervical NeoplasmsOropharyngeal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A